메뉴 건너뛰기




Volumn 54, Issue 4, 1998, Pages 1390-1391

Evidence that TGF-β should be a therapeutic target in diabetic nephropathy

Author keywords

Cell matrix interaction; Fibrosis; Glycemic control; Matrix degredation; ig h3

Indexed keywords

ANGIOTENSIN; TRANSFORMING GROWTH FACTOR ALPHA;

EID: 0031656012     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1998.00127.x     Document Type: Editorial
Times cited : (141)

References (10)
  • 1
    • 0028109801 scopus 로고
    • Transforming growth factor-β in tissue fibrosis
    • W.A. Border N.A. Noble Transforming growth factor- β in tissue fibrosis N Engl J Med 331 1994 1286 1292
    • (1994) N Engl J Med , vol.331 , pp. 1286-1292
    • Border, W.A.1    Noble, N.A.2
  • 3
    • 0030512150 scopus 로고    scopus 로고
    • Transforming growth factor β in diabetic nephropathy
    • W.A. Border T. Yamamoto N.A. Noble Transforming growth factor β in diabetic nephropathy Diab Metab Rev 12 1996 309 339
    • (1996) Diab Metab Rev , vol.12 , pp. 309-339
    • Border, W.A.1    Yamamoto, T.2    Noble, N.A.3
  • 4
    • 0029076281 scopus 로고
    • Hyperglycemia and diabetic kidney disease. The case for transforming growth factor-β as a key mediator
    • K. Sharma F.N. Ziyadeh Hyperglycemia and diabetic kidney disease. The case for transforming growth factor- β as a key mediator Diabetes 44 1995 1139 1146
    • (1995) Diabetes , vol.44 , pp. 1139-1146
    • Sharma, K.1    Ziyadeh, F.N.2
  • 5
    • 0027479442 scopus 로고
    • Expression of transforming growth factor-β is elevated in human and experimental diabetic nephropathy
    • T. Yamamoto T. Nakamura N.A. Noble E. Ruoslahti W.A. Border Expression of transforming growth factor- β is elevated in human and experimental diabetic nephropathy Proc Natl Acad Sci USA 90 1993 1814 1818
    • (1993) Proc Natl Acad Sci USA , vol.90 , pp. 1814-1818
    • Yamamoto, T.1    Nakamura, T.2    Noble, N.A.3    Ruoslahti, E.4    Border, W.A.5
  • 6
    • 0029924637 scopus 로고    scopus 로고
    • Neutralization of TGF-β by anti-TGF-β antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZ-induced diabetic mice
    • K. Sharma Y. Jin J. Guo F.N. Ziyadeh Neutralization of TGF- β by anti-TGF- β antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZ-induced diabetic mice Diabetes 45 1996 522 530
    • (1996) Diabetes , vol.45 , pp. 522-530
    • Sharma, K.1    Jin, Y.2    Guo, J.3    Ziyadeh, F.N.4
  • 9
    • 0031601718 scopus 로고    scopus 로고
    • Interactions of TGF-β and angiotensin II in renal fibrosis
    • W.A. Border N.A. Noble Interactions of TGF- β and angiotensin II in renal fibrosis Hypertension S31 1998 181 188
    • (1998) Hypertension , vol.S31 , pp. 181-188
    • Border, W.A.1    Noble, N.A.2
  • 10
    • 0030924446 scopus 로고    scopus 로고
    • Angiotensin II in renal fibrosis: should TGF-β rather than blood pressure be the therapeutic target?
    • N.A. Noble W.A. Border Angiotensin II in renal fibrosis: should TGF- β rather than blood pressure be the therapeutic target? Semin Nephrol 17 1997 455 466
    • (1997) Semin Nephrol , vol.17 , pp. 455-466
    • Noble, N.A.1    Border, W.A.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.